Your browser doesn't support javascript.
loading
PDGFB-targeted functional MRI nanoswitch for activatable T1-T2 dual-modal ultra-sensitive diagnosis of cancer.
Zhang, Ya'nan; Liu, Lu; Li, Wenling; Zhang, Caiyun; Song, Tianwei; Wang, Peng; Sun, Daxi; Huang, Xiaodan; Qin, Xia; Ran, Lang; Tian, Geng; Qian, Junchao; Zhang, Guilong.
Afiliação
  • Zhang Y; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Liu L; Hefei Cancer Hospital, Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, People's Republic of China.
  • Li W; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Zhang C; School of Pharmacy, Institute of Aging Medicine, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Song T; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Wang P; School of Pharmacy, Institute of Aging Medicine, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Sun D; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Huang X; School of Pharmacy, Institute of Aging Medicine, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Qin X; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Ran L; School of Pharmacy, Institute of Aging Medicine, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Tian G; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Qian J; School of Pharmacy, Institute of Aging Medicine, Binzhou Medical University, Yantai, 264003, People's Republic of China.
  • Zhang G; School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.
J Nanobiotechnology ; 21(1): 9, 2023 Jan 06.
Article em En | MEDLINE | ID: mdl-36609374
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Meios de Contraste / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Meios de Contraste / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article